These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3486623)

  • 1. [Sclerodermiform and poikilodermic syndrome during treatment with carbidopa and 5-hydroxytryptophan. Culture of fibroblasts with biochemical analysis of collagen metabolism].
    Chamson A; Périer C; Frey J
    Ann Dermatol Venereol; 1986; 113(1):71. PubMed ID: 3486623
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
    Sternberg EM; Van Woert MH; Young SN; Magnussen I; Baker H; Gauthier S; Osterland CK
    N Engl J Med; 1980 Oct; 303(14):782-7. PubMed ID: 6997735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-related scleroderma-like illness. The Fine page.
    Fine RM
    Int J Dermatol; 1981 Jun; 20(5):354. PubMed ID: 6972361
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxic oil syndrome (Spanish oil disease) and chemically induced scleroderma-like conditions.
    Rush PJ; Bell MJ; Fam AG
    J Rheumatol; 1984 Jun; 11(3):262-4. PubMed ID: 6204046
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sclerodermiform and poikilodermal syndrome observed during treatment with carbidopa and 5-hydroxytryptophan].
    Auffranc JC; Berbis P; Fabre JF; Garnier JP; Privat Y
    Ann Dermatol Venereol; 1985; 112(9):691-2. PubMed ID: 4091416
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
    Joly P; Lampert A; Thomine E; Lauret P
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 1):332-3. PubMed ID: 1918474
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ; Sharpless NS; Wolfson L; Katzman R
    Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Scleroderma-like syndrome with bullous morphea during treatment with 5-hydroxytryptophan, carbidopa and flunitrazepam].
    Lampert A; Joly P; Thomine E; Ortoli JC; Lauret P
    Ann Dermatol Venereol; 1992; 119(3):209-11. PubMed ID: 1605525
    [No Abstract]   [Full Text] [Related]  

  • 9. Myoclonus and L-5-hydroxytryptophan (L-5HTP).
    Van Woert MH
    Prog Clin Biol Res; 1983; 127():43-52. PubMed ID: 6351100
    [No Abstract]   [Full Text] [Related]  

  • 10. Silica induced scleroderma--clinical and experimental aspects.
    Haustein UF; Anderegg U
    J Rheumatol; 1998 Oct; 25(10):1917-26. PubMed ID: 9779844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palatal myoclonus: treatment with 5-hydroxytryptophan and carbidopa.
    Bhatt M; Snow B; Varelas M; Calne D
    Mov Disord; 1990; 5(4):339-40. PubMed ID: 2259361
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of isoproterenol on collagen synthesis in cultured skin fibroblasts in patients with systemic scleroderma].
    Khokhova IuV; Panasiuk AF; Grozdova MD
    Vopr Med Khim; 1984; 30(6):92-4. PubMed ID: 6098995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline does not alter collagen type I metabolism of dermal fibroblasts in culture.
    Anderegg U; Prieb J; Hildebrandt G; Saalbach A
    Arch Dermatol Res; 2002 May; 294(3):103-8. PubMed ID: 12029495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model.
    Liu S; Kapoor M; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2817-21. PubMed ID: 19714619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instability in the response to DST in major depressions during treatment with 5-hydroxytryptophan and carbidopa.
    Lopez-Ibor JJ; Saiz-Ruiz J; Perez de los Cobos JC
    Acta Psychiatr Belg; 1985; 85(3):450-8. PubMed ID: 3876688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serotonin metabolism in severe depression. Clinical and biochemical changes and the contribution of precursors].
    Pérez de los Cobos Peris JC
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(4):247-57. PubMed ID: 6334979
    [No Abstract]   [Full Text] [Related]  

  • 17. ATX-S10(Na)-PDT shows more potent effect on collagen metabolism of human normal and scleroderma dermal fibroblasts than ALA-PDT.
    Takahashi H; Komatsu S; Ibe M; Ishida-Yamamoto A; Nakajima S; Sakata I; Iizuka H
    Arch Dermatol Res; 2006 Nov; 298(6):257-63. PubMed ID: 16977444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleomycin-induced scleroderma.
    Finch WR; Rodnan GP; Buckingham RB; Prince RK; Winkelstein A
    J Rheumatol; 1980; 7(5):651-9. PubMed ID: 6160247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of serum from patients with systemic scleroderma on collagen biosynthesis in the fibroblasts before and after administration of antilymphocyte globulin].
    Panasiuk AF; Lebedev DA; Gandzha IM; Iashchenko OB
    Ter Arkh; 1983; 55(2):113-5. PubMed ID: 6845188
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.